Entropy Technologies’s Bio-Techne TECH Stock Holding History

Entropy Technologies’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,386	Closed	-$431K	–	1090
2025 Q2	$431K	Buy	+8,386	New	+$421K	0.03%	519

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Entropy Technologies's TECH Position: Q3 2025 in Review

Entropy Technologies sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 8,386 shares — an estimated $431K sold.

Entropy Technologies first reported a position in TECH in Q2 2025 and held it in 1 quarter. The position peaked at $431K in Q2 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

Entropy Technologies reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
Entropy Technologies sold 8,386 Bio-Techne shares in Q3 2025, an estimated $431K.
Entropy Technologies first reported a position in Bio-Techne in Q2 2025 and held it in 1 quarter.
Entropy Technologies's Bio-Techne position peaked at $431K in Q2 2025.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Entropy Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.